Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition and the
Biogen’s (BIIB) long-term prospects look intact despite Alzheimer’s drug setback
Categories
Health Care
PetIQ Inc. (PETQ) Q1 2022 Earnings Call Transcript
PetIQ Inc. (NASDAQ: PETQ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive Officer and
Jazz Pharmaceuticals PLC (JAZZ) Q1 2022 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Andrea N. Flynn -- Vice President, Head, Investor Relations
10X Genomics Inc. (TXG) Q1 2022 Earnings Call Transcript
10X Genomics Inc. (NASDAQ: TXG) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Cassie Corneau -- Manager, Investor Relations & Strategic Finance
CVS Health Corporation (CVS) Q1 2022 Earnings Call Transcript
CVS Health Corporation (NYSE: CVS) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Tom Cowhey -- Senior Vice President, Capital Markets Karen
Regeneron Pharmaceuticals Inc. (REGN) Q1 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Ryan Crowe -- Vice President of Investor Relations Leonard
Moderna Inc. (MRNA) Q1 2022 Earnings Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head of Investor
CVS Health Earnings Q1 2022: Here are the key highlights from the results
CVS Health (NYSE: CVS) reported first quarter 2022 earnings results today. Total revenues for the quarter increased to $76.8 billion, up 11.2%
Pfizer Inc. (PFE) Q1 2022 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q1 2022 earnings call dated May. 03, 2022 Corporate Participants: Chris Stevo -- Senior Vice President and Chief of Investor
Sage Therapeutics Inc. (SAGE) Q1 2022 Earnings Call Transcript
Sage Therapeutics Inc. (NASDAQ: SAGE) Q1 2022 earnings call dated May. 03, 2022 Corporate Participants: Helen Rubinstein -- Investor Relations Barry Greene -- Chief Executive Officer
Stock Watch: Should you invest in Eli Lilly (LLY) after Q1 earnings?
For Eli Lilly and Company (NYSE: LLY), 2021 was a fruitful year in terms of financial performance and product development. Reflecting the
Pfizer (PFE) anticipates an increase in orders for Paxlovid in coming months due to virus mutations
Shares of Pfizer Inc. (NYSE: PFE) gained nearly 2% on Tuesday after the company delivered better-than-expected results for the first quarter of
Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It helps independent
Key highlights from Biogen’s (BIIB) Q1 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported first quarter 2022 earnings results today. Total revenue decreased 6% year-over-year to $2.53 billion. GAAP net income attributable
PFE Earnings: All you need to know about Pfizer’s Q1 2022 earnings results
Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today. Total revenues increased 77% year-over-year to $25.7 billion. Reported net income
Earnings: Highlights of Eli Lilly’s (LLY) Q1 2022 results
Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers also surpassed
AbbVie (ABBV) Q1 2022 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q1 2022 earnings call dated Apr. 29, 2022 Corporate Participants: Elizabeth Shea -- Vice President, Head of Investor Relations Richard A.
AstraZeneca PLC (AZN) Q1 2022 Earnings Call Transcript
AstraZeneca PLC (NYSE: AZN) Q1 2022 earnings call dated Apr. 29, 2022 Corporate Participants: Chris Sheldon -- Head of Investor Relations Pascal Soriot -- Executive Director
Eli Lilly and Company (LLY) Q1 2022 Earnings Call Transcript
Eli Lilly and Company (NYSE: LLY) Q1 2022 earnings call dated Apr. 28, 2022 Corporate Participants: Kevin Hern -- Vice President of Investor Relations
Merck & Co. Inc. (MRK) Q1 2022 Earnings Call Transcript
Merck & Co. Inc. (NYSE: MRK) Q1 2022 earnings call dated Apr. 28, 2022 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations
BioMarin Pharmaceutical Inc. (BMRN) Q1 2022 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q1 2022 earnings call dated Apr. 27, 2022 Corporate Participants: Traci McCarty -- Vice President, Investor Relations Jean-Jacques Bienaime -- Chairman